Overview
Mizuto Sato practices in Shinjuku, Japan. Sato is highly rated in 1 condition, according to our data. Their top areas of expertise are Neurofibromatosis Type 2 (NF2), Subdural Hematoma, Neurofibromatosis, and Acoustic Neuroma.
Their clinical research consists of co-authoring 21 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Neurofibromatosis Type 2 (NF2)
- Experienced
- Acoustic NeuromaSato isExperienced. Learn about Acoustic Neuroma.
- AstrocytomaSato isExperienced. Learn about Astrocytoma.
- Brain TumorSato isExperienced. Learn about Brain Tumor.
- Cerebral HypoxiaSato isExperienced. Learn about Cerebral Hypoxia.
- Cerebral Ventricle CancerSato isExperienced. Learn about Cerebral Ventricle Cancer.
- ChordomaSato isExperienced. Learn about Chordoma.